Free tool
Cell therapy stocks
We cover 3 companies grouped under the Cell therapy theme. The median market value in the group is $482.61M. Across the group, the median move over the past trading day is +0.27%. Price change over the past year runs from +8.7% to +14.5% across the middle 80 percent of the group, with a median of +9.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| SYNC.L | Syncona Limited | $923.83M | Small cap | +15.68% |
| DTSQ | DT Cloud Star Acquisition Corporation | $41.39M | Micro cap | +8.42% |
| DTSQU | DT Cloud Star Acquisition Corporation | — | Small cap | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.